Regulus Therapeutics Inc. (RGLS)

Regulus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	38.53	23.77	24.23	60.38	31.09
Short-Term Investments	37.25	-	14.93	-	-
Cash & Short-Term Investments	75.78	23.77	39.16	60.38	31.09
Cash Growth	218.83%	-39.31%	-35.15%	94.24%	-8.89%
Receivables	-	-	-	-	0.5
Inventory	3.49	3.01	3.01	3.01	3.31
Prepaid Expenses	3.02	1.34	1.85	1.78	1.83
Restricted Cash	0.06	0.06	0.06	0.06	-
Total Current Assets	82.35	28.18	44.08	65.24	36.73
Property, Plant & Equipment	1.81	2.54	2.58	2.85	0.73
Other Intangible Assets	0.03	0.03	0.06	0.08	0.13
Other Long-Term Assets	-	-	-	0.29	0.02
Total Assets	84.18	30.75	46.72	68.45	37.6
Accounts Payable	0.95	0.2	0.18	0.29	0.54
Accrued Expenses	5.4	4.59	4.42	3.65	3.42
Current Portion of Long-Term Debt	-	1.33	4.51	-	4.65
Current Portion of Leases	0.78	0.71	0.65	0.59	0.47
Other Current Liabilities	0.37	1.67	1.9	0.71	2.5
Total Current Liabilities	7.5	8.51	11.66	5.23	11.58
Long-Term Debt	-	-	-	4.67	-
Long-Term Leases	0.27	1.06	1.77	2.42	-
Other Long-Term Liabilities	-	-	-	1.18	-
Total Liabilities	7.77	9.56	13.43	13.5	11.58
Common Stock	0.07	0.02	0.02	0.02	0.07
Additional Paid-In Capital	635.86	534.38	516.46	509.79	453
Retained Earnings	-559.57	-513.21	-483.18	-454.85	-427.05
Comprehensive Income & Other	0.05	-	-0.01	-	-
Total Common Equity	76.4	21.18	33.29	54.95	26.02
Shareholders' Equity	76.41	21.19	33.29	54.96	26.03
Total Liabilities & Equity	84.18	30.75	46.72	68.45	37.6
Total Debt	1.06	3.1	6.93	7.68	5.13
Net Cash (Debt)	74.72	20.67	32.23	52.7	25.96
Net Cash Growth	261.59%	-35.89%	-38.84%	103.00%	41.26%
Net Cash Per Share	1.33	1.09	2.11	6.15	7.42
Filing Date Shares Outstanding	66.24	65.47	16.84	14.6	7.25
Total Common Shares Outstanding	65.5	20.22	16.84	14.6	6.74
Working Capital	74.85	19.67	32.42	60.01	25.15
Book Value Per Share	1.17	1.05	1.98	3.76	3.86
Tangible Book Value	76.38	21.15	33.22	54.87	25.9
Tangible Book Value Per Share	1.17	1.05	1.97	3.76	3.84
Machinery	5.41	5.07	4.84	4.48	5.25
Construction In Progress	-	0.13	-	-	-
Leasehold Improvements	0.12	0.12	0.12	0.12	0.08

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q